LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹106 Cr | ₹107 Cr | ₹133 Cr | ₹145 Cr | ₹152 Cr |
What is the latest Total Non-Current Assets ratio of LYKA LABS ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹106 Cr |
Mar2023 | ₹107 Cr |
Mar2022 | ₹133 Cr |
Mar2021 | ₹145 Cr |
Mar2020 | ₹152 Cr |
How is Total Non-Current Assets of LYKA LABS Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹106 Cr | -1.16 | |
Mar2023 | ₹107 Cr | -19.56 | |
Mar2022 | ₹133 Cr | -7.73 | |
Mar2021 | ₹145 Cr | -4.88 | |
Mar2020 | ₹152 Cr | - |
Compare Total Non-Current Assets of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹415.4 Cr | -2.6% | 8.8% | 10.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -2.6% |
8.8% |
10.1% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses